Clinical Trial Results:
            Ceftidoren versus levofloxacin in the treatment of patients with Acute Exacerbations of Chronic Bronchitis (AECB). Multi-centre,  open-label, randomised, levofloxacin-controlled,  parallel groups study, pilot study to evaluate the effects of the treatment on serum  inflammatory biomarkers
    
|     Summary | |
|     EudraCT number | 2011-000531-88 | 
|     Trial protocol | IT | 
|     Global completion date | 
                                    30 Apr 2012
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    02 Jan 2020
                             | 
|     First version publication date | 
                                    02 Jan 2020
                             | 
|     Other versions | |
|     Summary report(s) | Published report | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
